An AI Drug Company Named a Candidate for Dry Macular Degeneration, and the Target Is Undisclosed
Insilico Medicine nominated ISM9077 for dry AMD and other eye diseases. What a preclinical candidate designation means and what remains undisclosed.
Medical Daily ·